Cargando…
Brief International Cognitive Assessment for MS (BICAMS): international standards for validation
An international expert consensus committee recently recommended a brief battery of tests for cognitive evaluation in multiple sclerosis. The Brief International Cognitive Assessment for MS (BICAMS) battery includes tests of mental processing speed and memory. Recognizing that resources for validati...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607849/ https://www.ncbi.nlm.nih.gov/pubmed/22799620 http://dx.doi.org/10.1186/1471-2377-12-55 |
_version_ | 1782264153282445312 |
---|---|
author | Benedict, Ralph HB Amato, Maria Pia Boringa, Jan Brochet, Bruno Foley, Fred Fredrikson, Stan Hamalainen, Paivi Hartung, Hans Krupp, Lauren Penner, Iris Reder, Anthony T Langdon, Dawn |
author_facet | Benedict, Ralph HB Amato, Maria Pia Boringa, Jan Brochet, Bruno Foley, Fred Fredrikson, Stan Hamalainen, Paivi Hartung, Hans Krupp, Lauren Penner, Iris Reder, Anthony T Langdon, Dawn |
author_sort | Benedict, Ralph HB |
collection | PubMed |
description | An international expert consensus committee recently recommended a brief battery of tests for cognitive evaluation in multiple sclerosis. The Brief International Cognitive Assessment for MS (BICAMS) battery includes tests of mental processing speed and memory. Recognizing that resources for validation will vary internationally, the committee identified validation priorities, to facilitate international acceptance of BICAMS. Practical matters pertaining to implementation across different languages and countries were discussed. Five steps to achieve optimal psychometric validation were proposed. In Step 1, test stimuli should be standardized for the target culture or language under consideration. In Step 2, examiner instructions must be standardized and translated, including all information from manuals necessary for administration and interpretation. In Step 3, samples of at least 65 healthy persons should be studied for normalization, matched to patients on demographics such as age, gender and education. The objective of Step 4 is test-retest reliability, which can be investigated in a small sample of MS and/or healthy volunteers over 1–3 weeks. Finally, in Step 5, criterion validity should be established by comparing MS and healthy controls. At this time, preliminary studies are underway in a number of countries as we move forward with this international assessment tool for cognition in MS. |
format | Online Article Text |
id | pubmed-3607849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36078492013-03-27 Brief International Cognitive Assessment for MS (BICAMS): international standards for validation Benedict, Ralph HB Amato, Maria Pia Boringa, Jan Brochet, Bruno Foley, Fred Fredrikson, Stan Hamalainen, Paivi Hartung, Hans Krupp, Lauren Penner, Iris Reder, Anthony T Langdon, Dawn BMC Neurol Correspondence An international expert consensus committee recently recommended a brief battery of tests for cognitive evaluation in multiple sclerosis. The Brief International Cognitive Assessment for MS (BICAMS) battery includes tests of mental processing speed and memory. Recognizing that resources for validation will vary internationally, the committee identified validation priorities, to facilitate international acceptance of BICAMS. Practical matters pertaining to implementation across different languages and countries were discussed. Five steps to achieve optimal psychometric validation were proposed. In Step 1, test stimuli should be standardized for the target culture or language under consideration. In Step 2, examiner instructions must be standardized and translated, including all information from manuals necessary for administration and interpretation. In Step 3, samples of at least 65 healthy persons should be studied for normalization, matched to patients on demographics such as age, gender and education. The objective of Step 4 is test-retest reliability, which can be investigated in a small sample of MS and/or healthy volunteers over 1–3 weeks. Finally, in Step 5, criterion validity should be established by comparing MS and healthy controls. At this time, preliminary studies are underway in a number of countries as we move forward with this international assessment tool for cognition in MS. BioMed Central 2012-07-16 /pmc/articles/PMC3607849/ /pubmed/22799620 http://dx.doi.org/10.1186/1471-2377-12-55 Text en Copyright ©2012 Benedict et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Correspondence Benedict, Ralph HB Amato, Maria Pia Boringa, Jan Brochet, Bruno Foley, Fred Fredrikson, Stan Hamalainen, Paivi Hartung, Hans Krupp, Lauren Penner, Iris Reder, Anthony T Langdon, Dawn Brief International Cognitive Assessment for MS (BICAMS): international standards for validation |
title | Brief International Cognitive Assessment for MS (BICAMS): international standards for validation |
title_full | Brief International Cognitive Assessment for MS (BICAMS): international standards for validation |
title_fullStr | Brief International Cognitive Assessment for MS (BICAMS): international standards for validation |
title_full_unstemmed | Brief International Cognitive Assessment for MS (BICAMS): international standards for validation |
title_short | Brief International Cognitive Assessment for MS (BICAMS): international standards for validation |
title_sort | brief international cognitive assessment for ms (bicams): international standards for validation |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607849/ https://www.ncbi.nlm.nih.gov/pubmed/22799620 http://dx.doi.org/10.1186/1471-2377-12-55 |
work_keys_str_mv | AT benedictralphhb briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT amatomariapia briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT boringajan briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT brochetbruno briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT foleyfred briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT fredriksonstan briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT hamalainenpaivi briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT hartunghans briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT krupplauren briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT penneriris briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT rederanthonyt briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation AT langdondawn briefinternationalcognitiveassessmentformsbicamsinternationalstandardsforvalidation |